The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 18, 2014

Filed:

Mar. 11, 2011
Applicants:

Joseph S. Raven, Goleta, CA (US);

Janel A. Birk, Oxnard, CA (US);

Inventors:

Joseph S. Raven, Goleta, CA (US);

Janel A. Birk, Oxnard, CA (US);

Assignee:

Apollo Endosurgery, Inc., Austin, TX (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61F 5/00 (2006.01); A61B 5/07 (2006.01); A61M 5/142 (2006.01); A61B 5/00 (2006.01); A61M 5/172 (2006.01); A61B 5/03 (2006.01); A61M 5/168 (2006.01); A61F 2/04 (2013.01); A61N 1/36 (2006.01); A61N 1/05 (2006.01);
U.S. Cl.
CPC ...
A61F 5/0076 (2013.01); A61M 2205/50 (2013.01); A61B 5/073 (2013.01); A61M 2205/0294 (2013.01); A61M 2230/005 (2013.01); A61M 5/14276 (2013.01); A61M 5/1684 (2013.01); A61M 2210/1057 (2013.01); A61F 2250/0001 (2013.01); A61M 2205/3569 (2013.01); A61M 2205/0244 (2013.01); A61M 2205/8206 (2013.01); A61F 2002/045 (2013.01); A61M 2205/3523 (2013.01); A61B 5/4839 (2013.01); A61N 1/36057 (2013.01); A61F 2250/0068 (2013.01); A61N 1/0517 (2013.01); A61B 5/4255 (2013.01); A61M 2230/20 (2013.01); A61B 5/746 (2013.01); A61M 5/1723 (2013.01); A61M 5/14224 (2013.01); A61F 2/04 (2013.01); A61M 2205/8243 (2013.01); A61N 1/0509 (2013.01); A61N 1/36085 (2013.01); A61B 5/0031 (2013.01); A61B 5/036 (2013.01); A61M 2005/1726 (2013.01);
Abstract

An intraluminal sleeve system is provided, which generally includes an intraluminal sleeve capable of dispensing an active agent to a patient, for example, a metabolic agent or satiety inducing agent. The intraluminal sleeve may be structured to contain the active agent and permit controlled release of the active agent to the patient while the intraluminal sleeve is positioned within the patient's intestine. Methods for treating obesity are also provided which include positioning an intraluminal sleeve in a patient's intestine, the intraluminal sleeve being capable of dispensing an active agent to the patient. In one embodiment, the active agent may be contained in a reservoir and dispensed to a portion of the patient's body.


Find Patent Forward Citations

Loading…